Rotavirus causes severe diarrheal disease in children worldwide. A hallmark of rotavirus 27 infection is an increase in cytosolic calcium in infected small intestine epithelial cells. However, mice. This is the first evidence that viruses exploit intercellular calcium waves to amplify diarrheal 37 signaling; a finding which have broad implications for gastrointestinal physiology. 38
Introduction 39
Rotavirus (RV), a non-enveloped double-stranded RNA virus of the Reoviridae family, 40 causes severe diarrhea and vomiting in children worldwide, responsible for ~258 million diarrhea 41 episodes and ~128,000 deaths annually 1 . Though the pathways by which other enteric pathogens 42 cause diarrhea are well-characterized, such as cholera toxin of Vibrio cholerae, the mechanisms 43 of RV diarrhea are multifactorial and still not completely understood. RV infects the epithelial 44 enterocytes and enteroendocrine cells at the tip and middle of villi in the small intestine. Notably, 45 only a percentage of cells susceptible to RV are infected, and diarrhea occurs before the onset of 46 histopathologic changes [2] [3] [4] [5] . During infection, RV dysregulates host cell calcium (Ca 2+ ) signaling 47 pathways to increase cytosolic Ca 2+ , which is required for RV replication. The RV nonstructural 48 protein 4 (NSP4) drives these changes in Ca 2+ homeostasis as both an intracellular viral ion 49 channel (i.e., viroporin) in the endoplasmic reticulum and an extracellular enterotoxin that elicits 50 a phospholipase-C-dependent increase in cytosolic Ca 2+ 6-8 . These perturbations to host Ca 2+ 51 signaling are known to activate autophagy, disrupt the cytoskeleton and tight junctions, and trigger 52 fluid secretion pathways 7,9-12 . 53
A long-held hypothesis in how RV infection causes life-threatening diarrhea is that RV-54 infected cells release potent signaling molecules that can dysregulate neighboring, uninfected 55 cells 4, 13, 14 . This premise is based on previous studies that have identified increases in candidate 56 monolayers (Fig. 3H,I ). Together, this data supports that RV-induced ICWs in intestinal epithelial 226 cells occur by extracellular ADP signaling and the P2Y1 receptor, the same as in MA104 cells. 227
228

CRISPR/Cas9 P2Y1 receptor knockout reduces intercellular calcium waves 229
Pharmacological studies of purinergic receptors have found that different receptors have 230 distinct affinities for nucleotide binding, with the P2Y1 receptor having greater activation with ADP 231 than with ATP 36 . This suggests that ADP mediates the ICWs in RV infection, which is also 232 consistent with studies that have found that RV-infected cells have reduced cytoplasmic 233 concentrations of ATP 37 . To test whether ADP is the signaling molecule of the ICWs, we infected 234 MA104-GCaMP cells with RV (SA114F) and then treated with apyrase grade VI, which has a high 235
ATPase/ADPase activity ratio, or apyrase grade VII, which has a low ATPase/ADPase activity 236 ratio. Treatment with apyrase grade VII, but not grade VI, significantly decreased the number of 237 Ca 2+ spikes and the spike magnitude in RV-infected wells, supporting that ADP is the signaling 238 molecule in RV-induced ICWs (Fig. 4A,B) . To further test that the P2Y1 receptor is required for 239 RV-induced Ca 2+ waves, we genetically knocked out the P2Y1 receptor in MA104-GCaMP cells 240 using lentivirus encoding CRISPR/Cas9 with small-guide RNAs targeted for the P2Y1 receptor 241 gene (MA104-GCaMP-P2Y1ko). Genotyping analysis revealed several mutations in the 242 sequence downstream of the guide RNA in 3 clonal populations of cells (Extended Data Fig.  243   S3A,B) . To test the P2Y1 knockout phenotype, we added ADP to parental and MA104-GCaMP-244
P2Y1ko cells and found a significantly decreased Ca 2+ response in the knockout cells compared 245 to the parental GECI line, consistent with a lack of P2Y1 receptor function (Fig. 4C) . 246
Next, we sought to determine if knockout of the P2Y1 receptor would also prevent ICWs 247 during RV infection. We mock-or RV (SA114F)-infected MA104-GCaMP (parental) or MA104-248
GCaMP-P2Y1ko cells. Fixing and immunostaining for RV antigen at 24 hpi showed positive 249 staining for RV in parental and P2Y1 knockout cells confirming that the P2Y1 knockout did not 250 prevent infection (Fig. 4D) . In the P2Y1 knockout cells, there was a decrease in Ca 2+ signaling, 251 Ca 2+ spikes, and average Ca 2+ spike magnitude in the NB+3 and NB+5 cells compared with the 252 parental, though not in the RV-infected cell (Fig. 4E-G, Supplementary Video 8) . Additional 253 treatment of apyrase VII to the P2Y1 knockout cells only modestly decreased the Ca 2+ spikes in 254 neighboring cells (Fig. 4G) . 255 Similarly, we tested the effect of genetic knockout of the P2Y1 receptor on ICWs in RV-256 infected jHIEs (jHIE-GCaMP6s-P2Y1ko). Genotyping analysis revealed two P2Y1 knockout 257 enteroid populations comprising of an insertional mutation and a deletion in the sequence 258 downstream of the guide RNA (Extended Data Fig. S3C,D) . Phenotypic knockout was confirmed 259 by a reduced Ca 2+ response to ADP in jHIE-GCaMP6s-P2Y1ko enteroids compared to parental 260 enteroids (Fig. 5A ). For these studies we also created an additional jHIE-GCaMP6s enteroid line 261 with CRISPR/Cas9 knockout of the P2Y2 receptor (jHIE-GCaMP6s-P2Y2ko). Genotyping 262 analysis of the P2Y2ko enteroids detected two alleles with deletion mutations downstream of the 263 guide RNA sequence (Extended Data Fig. S4A,B) . To test the P2Y2 knockout phenotype, we 264 added non-hydrolyzable ATP-γS to parental and P2Y2ko enteroids and found a significantly 265 decreased Ca 2+ response in the P2Y2ko jHIEs (Fig. 5B) . Immunostaining the jHIE monolayers 266
for RV antigen at 24 hpi showed positive staining for RV in parental, P2Y1ko, and P2Y2ko 267 enteroids, demonstrating RV infection still occurred (Fig. 5C,D) . Mock-or RV (Ito)-infection of the 268 parental, jHIE-GCaMP6s-P2Y1ko, or jHIE-GCaMP6s-P2Y2ko resulted in significantly less Ca 2+ 269 signaling, Ca 2+ spikes/FOV, and smaller average Ca 2+ spike magnitude in the P2Y1 knockout 270 jHIEs, but not in P2Y2 knockout jHIEs (Fig. 5E-G, Supplementary Video 9) . Interestingly, there 271 was also significantly fewer Ca 2+ spikes/FOV and average Ca 2+ spike magnitude in the P2Y1 KO 272 enteroids compared to parental or P2Y2 knockout enteroids in mock-inoculation (Fig. 5F,G) . 273
Together, this data supports that ADP and the P2Y1 receptor mediate the ICWs in RV infection 274 and reduce basal ICW signaling. 275
276
Purinergic signaling increases RV replication and expression of IL-1α, iNOS, and COX2
Previous studies have found that extracellular ATP reduces the replication of several 278 viruses through activation of P2X7 receptors, which specifically bind ATP 38,39 . Less is known 279 about the role of ADP in cellular signaling or its effects on viral infection and replication. We first 280 tested the effect of purinergic blockers on RV replication. New infectious yield from RV (SA114F)-281 infected MA104 cells was decreased when treating cells with apyrase or BPTU after inoculation, 282 and no significant decrease was observed when adding AR-C 118925XX, Bx430, 5BDBD, or the 283 non-selective P2 receptor antagonists suramin and PPADS (Fig. 6A) . Furthermore, RV infectious 284 yield was also reduced from RV (SA11cl3-mRuby)-infected MA104-GCaMP-P2Y1ko cells 285 compared to parental MA104-GCaMP cells (Fig. 6B) . These results support that blocking ADP 286 signaling and the P2Y1 receptor decreases RV replication. 287 Extracellular ATP is also known to have pro-inflammatory functions and activate 288 components of the innate immune system such as macrophages 40, 41 . Previous studies have 289 found that RV increases expression and release of the inflammatory cytokine interleukin-1α (IL-290 1α), which is highly expressed in epithelial cells 42, 43 . Furthermore, strong cytosolic Ca 2+ agonists 291 can induce the secretion of IL-1α independent of inflammasome activation 44 . To determine if RV-292 induced ICWs increase IL-1α, we mock-or RV (Ito)-infected jHIE monolayers and treated with 293 apyrase or BPTU. RV infection significantly increased IL-1α expression over mock infection, and 294 treatment with apyrase or BPTU inhibited this increase (Fig. 6C) . This finding supports that RV-295 induced ICWs and ADP signaling increases IL-1α expression and thus mediates the inflammatory 296 response from HIEs. 297
Since increased PGE2 and NO have been found during RV infection, we also investigated 298 if RV-induced ICWs could stimulate their production [15] [16] [17] . Previous studies have found that 299 purinergic signaling stimulates cyclooxygenase-2 (COX2) expression and PGE2 release from 300
Caco-2 and rat-derived IEC-6 cell lines and can also activate inducible nitric oxide synthase 301 (iNOS) expression and nitric oxide production 45, 46 . To test the role of ADP signaling, we mock-or 302 RV (Ito)-infected jHIE monolayers and treated with apyrase or BPTU. RV infection significantly 303 increased both COX2 and iNOS expression over mock-infection, and treatment with apyrase or 304 BPTU inhibited this increase ( Fig. 6D-E) . These findings suggest that RV-induced ICWs and ADP 305 signaling increase the expression of COX2 and iNOS and thus potentially drive the increased 306 PGE2 and NO observed in RV infections. 307
308
Blocking purinergic signaling reduces serotonin and fluid secretion 309 RV infection causes a multifactorial secretory diarrhea, and two-thirds of the fluid secretion 310
can be attributed to activation of the enteric nervous system (ENS) 5 . Previous studies have found 311 that RV infection can stimulate the release of serotonin from enterochromaffin cells to activate the 312 ENS and blocking serotonin decreases diarrhea, making serotonin release a key mechanism for 313 RV-induced diarrhea 22, 47 . To determine if RV-induced ADP signaling could stimulate serotonin 314 secretion, we mock-or RV (Ito)-infected jHIE monolayers and treated with DMSO vehicle, 315 apyrase, or BPTU. After 24 hr, we found significantly increased serotonin in the supernatant of 316 RV-infected jHIE monolayers compared to mock-infection, which was significantly inhibited by 317 treatment with apyrase or BPTU (Fig. 6F) . Furthermore, treatment of RV-infected monolayers 318 with ω-agatoxin, a P-type voltage-gated Ca 2+ channel blocker, also significantly inhibited 319 serotonin levels, supporting that the measured serotonin was from cellular release rather than cell 320 death ( Fig. 6F) . We found similar results when infecting jHIE transwells, a more polarized model 321 of epithelium, with RV. Treatment with BPTU significantly decreased serotonin measured in both 322 the apical and basolateral compartments compared with DMSO vehicle and overall a greater 323 concentration of serotonin secreted basally (Fig. 6G) . This data support that ADP signaling 324 stimulates serotonin secretion during RV infection. 325 RV infection also activates secretory pathways in epithelial cells through the stimulation 326 of chloride secretion which drives paracellular movement of water. We tested whether RV-induced 327 ADP signaling was important for RV-induced epithelial fluid secretion using the enteroid swelling 328 assay, in which an increase in fluid secretion causes an increase in the internal lumen of threedimensional (3D) enteroid cultures 33,48 . We mock-or RV-infected 3D jHIE-GCaMP6s enteroids, 330 treated with DMSO vehicle or BPTU, and found that BPTU treatment significantly decreased the 331 percentage of swelling in RV-infected enteroids (Fig. 6H, Supplementary Video 10) . This result 332 supports that ADP signaling stimulates epithelial fluid secretion in RV infection. 333
Finally, we determined whether inhibition of the P2Y1 receptor would attenuate RV-334 induced diarrhea in a neonatal mouse model. BPTU consistently had the most potent inhibition of 335 Ca 2+ spikes and average Ca 2+ spike magnitude in HIEs (Fig. 3H,I ). We tested a drug treatment 336 model in which 6 to 8-day-old pups were orally gavaged with rhesus RV (RRV) and then gavaged 337 with BPTU or vehicle control on days 1-4 post-infection. Stools were assessed each day and 338 watery, mucus, yellow stools were indicators of diarrhea. Peak diarrhea occurred at 2 dpi in both 339 DMSO-and BPTU-treated pups, but the percentage of pups with diarrhea decreased significantly 340 on 4 dpi (Fig. 6I ). Pups treated with BPTU also had significantly less severe diarrhea as measured 341 by their mean diarrhea score (Fig. 6J) . Furthermore, the intestinal cross-sections from the 342 duodenum, jejunum, and ileum of RV-infected pups treated with DMSO or BPTU are relatively 343 similar with no histopathological features at 5 dpi (Fig. 6K) . These studies support that blocking 344 the P2Y1 receptor decreased diarrhea severity and caused diarrhea to resolve more quickly than 345 the untreated animals. 346
We next tested whether treatment with a water-soluble small molecule P2Y1 receptor 347 blocker, MRS2500, would similarly attenuate RV diarrhea. In these studies, we found there was 348 a decreased percentage of diarrhea in pups gavaged with MRS2500 on 1 dpi compared to pups 349 treated with normal saline, but on other dpi, there were similar percentages of diarrhea (Extended 350 Data Fig. S5A ). Pups treated with MRS2500 also had significantly less severe diarrhea on 1 dpi 351 and 3 dpi than pups treated with saline (Extended Data Fig. S5B ). These results further support 352 that inhibition of P2Y1 decreases RV diarrhea severity. 353
Finally, we used a neonatal mouse model of RV diarrhea using a constitutive knockout of 354 the P2Y1 receptor 49 . Interestingly, RRV infection of the P2Y1 knockout mice did not abolish RV-355 induced diarrhea (Extended Data Fig. S5C,D) . We measured the purinergic receptor expression 356 in neonatal jejunum epithelium in a C57Bl/6 background and in the P2Y1 knockout mice. With the 357 exception of P2Y1 transcripts, we found similar relative expression levels of P2X4, P2Y2, P2Y6, 358 and P2Y13 in both mice (Extended Data Fig. S5E,F Six-or seven-day-old mouse pups were orally gavaged with 1.5 x 10 5 PFU/mL of Rhesus 431 rotavirus, a dosage sufficient to cause diarrhea in 100% of pups. The inoculum was mixed with 432 sterile-filtered green food dye (3% by volume) for visualization of the gavage. For BPTUexperiments, pups were orally gavaged with BPTU (4 mg/kg) (4 cages, n = 30 pups) or an 434 equivalent volume of DMSO vehicle control (4 cages, n = 26 pups) suspended in pharmaceutical 435 grade corn oil on days 1-4 post-infection. For MRS2500 experiments, pups were orally gavaged 436 with MRS2500 (4 mg/kg) (5 cages, n = 30 pups) or an equivalent volume of saline control (4 437 cages, n = 21 pups) suspended in pharmaceutical grade normal saline on days 1-4 post-infection. 438
Four cages with a total of 30 pups were used in P2Y1 -/-experiments. Each day, mouse pups were 439 gently palpated on the abdomen to express and visualize feces. Stools were assessed on a scale 440 between 1-4 for volume, color, and consistency as described previously 7 , an average score of 441 ≥2 was considered diarrhea. For scoring consistency, select experiments were scored by an 442 observer blinded to experimental condition. Percentage of pups with diarrhea was calculated as 443 the number of stools with a diarrhea score ≥ 2 divided by the number of stools collected per cage 444 per day. Pups from which a stool sample could not be collected on that day were not counted for 445 percent diarrhea or mean diarrhea severity calculations. GECI constructs were packaged in HEK293T cells as previously described 59 or produced 466 commercially (Cyagen Biosciences, Inc.). MA104-GCaMP5G, MA104-GCaMP5G/RCEPIAer, 467 MA104-RGECO1/GCEPIAer, and the MA104-GCaMP6s-shRNA lines and jHIE-CaMP6s 468 enteroids (from patient J3) were generated as previously described 26, 59 . Both MA104-GCaMP5G 469 and MA104-GCaMP6s cells were used in these studies; we observed no difference in calcium 470 responses with these two indicators and thus refer to both as MA104-GCaMP. Jejunum human 471 intestinal enteroids from patient J2 expressing GCaMP6s (in pLVX-IRES-Hygro) were created 472 using lentivirus transduction as described previously and grown in high Wnt3a CMGF+ with 50 473 µg/mL hygromycin B for selection 60 . CRISPR/Cas9. The patient J2-derived jHIE-GCaMP6s(hygro) enteroids described above were 484 transduced with the CRISPR/Cas9-expressing constructs to make two separate enteroid lines 485 and grown with 50 g/mL hygromycin B and 1 g/mL puromycin to select for co-expression of 486
GCaMP6s and CRISPR/Cas9. 487
Genotyping was performed on whole genomic DNA prepared using DirectPCR (Viagen) 488
with Proteinase K (Qiagen) according to manufacturer's instructions. Genomic DNA was a 489 template to PCR amplify a region surrounding the P2Y1 or P2Y2 sgRNA-target sites using primers 490 listed in Extended Data Table 1 software (GraphPad Inc., La Jolla, CA). Outlier data points were removed using the ROUT method 630 (Q = 1%). Statistical comparisons were made using Mann-Whitney test, one-way Analysis of 631 Variance (ANOVA), or the Kruskal-Wallis test and the Tukey, Bonferroni, or Dunn's multiple 632 comparisons test. Differences between the groups were considered significant at p < 0.05 (*), and 633 the data are presented as mean ± standard deviation unless otherwise noted. All authors had 634 access to the study data, reviewed, and approved the final manuscript. 635
636
Data availability. The data that support the findings of this study are available from the 637 corresponding author upon reasonable request.
